Get the Daily Brief
Latest Biotech News
Regulatory approvals – thyroid eye disease
Viridian Therapeutics secured FDA approval for Lumvoa (veligrotug-vvze) for thyroid eye disease, covering both chronic and active phases. The decision also includes labeling and dosing updates...
AI-assisted cancer vaccines – manufacturing buildout
China broke ground on what developers describe as the first AI-powered production line for personalized tumor vaccines in Beijing. Likang Life Sciences said the facility will support lab work and...
Protein-structure AI advances – experiment-guided AlphaFold
Researchers at the Institute of Science and Technology Austria (ISTA) and collaborators published Nature Biotechnology work showing how to guide AlphaFold using experimental data to address its...
Genomic engineering – retargeted serine integrases and recombinases
Nature Biotechnology published multiple advances to expand precise genome engineering using retargeted serine-based enzymes. One report describes retargeted serine integrases designed to...
AI drug discovery collaboration – Insilico and SK Biopharmaceuticals
Insilico Medicine and SK Biopharmaceuticals announced an AI-based drug collaboration targeting neuroimmune disorders in the central nervous system. The partnership could generate up to $2.5...
AI-native biotech platforms – Edison Scientific spun out
Edison Scientific, spun out of FutureHouse, is being tapped by the team behind Metsera to create new biotechs using AI agents. The article describes FutureHouse’s early fundraising attempts to...
Clinical research – menstrual cycle effects on COVID-19 vaccine outcomes
A study in npj Women’s Health reported that menstrual cycle phase may influence COVID-19 vaccine side-effect reporting. Using menstrual cycle data from a period tracking app matched to vaccination...
Drug development and investing – mRNA context with Moderna co-founder
In an interview, Moderna co-founder Kenneth Chien discussed the future of mRNA technology and Moderna’s positioning, tying the company’s early growth to a high-profile partnership that accelerated...
Preclinical biotech – cost reduction in cell-free systems
A research team led by Professor Joongoo Lee at POSTECH reported a method to cut the cost of building reconstituted cell-free systems by 95%. The work uses an automated, modular assembly approach...
Research integrity and funding oversight – whistleblower case advances
A federal judge allowed most of a whistleblower lawsuit against Harvard to proceed, letting claims alleging misuse of National Institutes of Health (NIH) grant funds move forward. The case, filed...
AI protein-structure modeling with experimental constraints
Researchers at IST Austria and international collaborators reported an approach to steer AlphaFold using experimental data to address a key limitation: the model’s tendency to collapse...
Regulatory approval – first-in-class competitive therapy for thyroid eye disease
FDA approved Viridian Therapeutics’ Lumvoa (veligrotug-vvze) for thyroid eye disease, covering both chronic and active phases. The approval positions the IGF-1R antagonist as a direct alternative...
Drug development platforms – AI neuroimmune collaboration with major biotech
Insilico Medicine and SK Biopharmaceuticals launched an AI-based neuroimmune drug collaboration that could generate up to $2.5 billion in value for Insilico’s efforts. Under the deal, Insilico...
Academic-industry integrity – whistleblower bid to proceed against Harvard Catalyst
A federal judge allowed most of a whistleblower lawsuit against Harvard to proceed, ruling that two claims can move forward accusing the University and a Harvard Catalyst principal investigator of...
Cell-free manufacturing innovation – 95% cost reduction for reconstituted systems
A research team led by POSTECH Professor Joongoo Lee reported a modular, automated method for assembling reconstituted cell-free systems and said it cut the cost of building these...
Company creation in AI drug discovery – Edison Scientific spun out for agent-based discovery
Edison Scientific, an AI agent-based biotech discovery company, was tapped by the team behind obesity drug startup Metsera to create new biotechs. The story traces Edison’s origin from...
Clinical research – menstrual-cycle phase shifts COVID-19 vaccine side effects
Researchers using period tracking app data and a vaccination survey of 1,474 women reported that menstrual-cycle phase at vaccination correlated with different COVID-19 vaccine outcomes. Published...
Policy and compliance spotlight – biomedical regulation career and hiring not news
No high-impact biotech policy or regulatory career development article was provided beyond general job advice and unrelated submissions. These items were excluded to keep the newsletter focused on...
Healthcare delivery and reimbursement – excluded as non-biotech pipeline news
CMS star rating recalculations and GLP-1 coverage commentary were excluded because they were primarily payer-policy and healthcare operations coverage rather than discrete biotech R&D, regulatory,...
Neuroscience and cancer biology profiles – excluded as non-breaking R&D event
The provided cancer neuroscience “then and now” profile and other non-urgent research pieces were not included because they did not present a clearly time-critical biotech development (e.g., trial...